Total Equity Funding
$40M in 1 Round from 1 Investor
Most Recent Funding
$40M Series E on January 5, 2016
San Diego, CA
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Health Care, Biotechnology, Medical

Company Details


Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. Its general health and wellness tests, including PathwayFit®, Cardiac DNA Insight®, and SkinFit™, equip physicians and patients with genetic information to support lifestyle choices. Liquid biopsy tests, including CancerIntercept™ Detect and Monitor, are non-invasive tests for detection of circulating tumor DNA. Pathway’s pharmacogenomics tests (Mental Health DNA Insight® and Pain Medication DNA Insight®) provide genetic information to help guide selection of optimal medication for management of mental health and pain disorders. Pathway’s hereditary cancer risk tests, including BRCATrue® and ColoTrue®, evaluate genetic factors for future cancer risk. Pathway Genomics Corporation operates a clinical laboratory to provide its commercial genetic testing services to physicians and their patients in the United States and internationally. Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.

Funding Rounds (1) - $40M

DateAmount / RoundValuationLead InvestorInvestors
Jan, 2016$40M / Series E1

Investors (1)

Series E (Lead)-

Current Team (10)


Board Members and Advisors (1)


Products (15)

  • PathwayFIT® analyzes over 75 genetic markers known to impact metabolism, exercise, and energy use within the human body.
  • SkinFit™ is a unique, physician-ordered genetic test which analyzes over 70 genetic markers associated with seven categories of skin health.
  • Identifies genetic variants that affect the metabolism and efficacy of more than 30 common psychiatric medications.
  • Identifies genetic variants that affect how a person responds to the analgesic effects of certain types of commonly prescribed pain meds.
  • One of the most comprehensive weight-related genetic tests available, combining nutrigenetic, medication, & general health information.
  • Provides specific genetic info. including matching diet type, nutritional needs & genetic propensities - help reduce the heart disease risk.
  • Comprehensive analysis of BRCA1 and BRCA2, including 3 common Ashkenazi Jewish mutations & 8 recurrent pathogenic variants in Hispanic pop.
  • May help to better manage post-partum weight loss & provides information to promote improvement in overall health and wellness.

Offices/Locations (1)

  • Pathway Genomics Corp.

    4755 Nexus Center Drive

    San Diego, CA 92121


Images (1)


Add Acquisitions

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos